WHO ICTRP trial
Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of…
KCT0001633 · Clinical Research Information Service (CRIS) · Not Recruiting
Key facts
| Trial ID | KCT0001633 |
|---|---|
| Public title | Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of SA001 in Healthy Male |
| Scientific title | A block-randomized, double-blind, placebo-controlled, single-dose, dose-escalation, Phase I clinical study to investigate the pharmacokinetics and safety/tolerability of SA001 in healthy male volunteers |
| Primary sponsor | Samjin Pharmaceutical |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Not Recruiting |
| Study type | Interventional Study |
| Phase | Phase1 |
| Countries | Korea, Republic of |
| Conditions | Diseases of the eye and adnexa |
| Interventions | Drug : -Total number of subjects: 40 -Experimental Group: SA001 1 tablet, Single dose, Dose-escalation -Placebo Group: SA001 placebo 1 tablet, Single dose |
| Registration date | Sep 22, 2015 |
| Target size | 40 |
| Secondary IDs | NCT02470286 |
| Registry page | cris.nih.go.kr |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: